121 results
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
benefits over the existing standard of care, including the potential for cure in some patients.
We believe our leadership in T cell programming … product candidates;
the potential benefits of our product candidates;
the timing or likelihood of regulatory filings and approvals for our product
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
license agreement;
our plans to research, develop, manufacture and commercialize our product candidates;
the potential benefits of our product … or seek strategic alliances or enter into additional licensing arrangements in the future, and we may not realize the benefits of such alliances
10-K
2023 FY
EX-97.1
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Code Section 401(a)(13) or Code Section … termination under any benefits or compensation arrangement applicable to such Covered Officer, or (ii) to constitute a breach of a contract or other
8-K
AUTL
Autolus Therapeutics plc
21 Mar 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:21pm
(the “Company”) benefits from the U.K. research and development tax credit regime under the scheme for small or medium-sized enterprises (“SMEs”). Under
8-K/A
EX-99.1
AUTL
Autolus Therapeutics plc
15 Mar 24
Results of Operations and Financial Condition
4:21pm
tax benefits on the statement of operations. The company has revised its financial presentation, including the prior years and will now present
8-K
EX-99.2
4kuwm
14 Mar 24
Results of Operations and Financial Condition
12:32pm
8-K
EX-99.1
4u9j 7fp2obxzh1ksne
13 Feb 24
Regulation FD Disclosure
4:06pm
424B5
wmie rwlx
9 Feb 24
Prospectus supplement for primary offering
5:15pm
8-K
EX-1.1
m1m9k18xpce ni
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-99.1
tk5by5e
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
8-K
EX-10.2
wgve6o4 qrim3hu2ahb
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
xbmrt2leblly
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.7
uqjld9d9a 6ai2jza9
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.9
h36kzvo8r19095xo
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-4.10
4wsk3mzz3zlr641gvu
7 Feb 24
Automatic shelf registration
10:00pm
8-K
EX-99.2
i5bdjhx1simyi3yls2
11 Dec 23
Regulation FD Disclosure
8:31am
10-Q
EX-10.2
2h1fg7uf16ty
9 Nov 23
Quarterly report
4:18pm
10-Q
3o0bz
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.2
wf1gv uzz
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.1
frnol5riegqtp0ug
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm